|
| San Francisco |
8 May 08, 01:25 |
|
| WOODCLIFF LAKE, N.J. ( Map ) - WOODCLIFF LAKE, N.J. , May 7 /PRNewswire/ -- Eisai Corporation of North America and its U.S. subsidiary, MGI PHARMA, INC., today announced that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetic and Life Support Drugs (ALSDAC) has voted 6 to 3 in favor (with one abstention) of approval of fospropofol disodium injection for use as an ... |
| more |
|
